NCR3LG1 and neoplasm: Chemotherapeutic agents have also been shown to sensitize tumor cells to NK cell cytolysis through the induction of ligands on the tumor surface such as MICA/B, ULPBs and B7-H6 that bind activating NK receptors (92).